Why Aren’t the Largest Thyroid Nodules Biopsied First?

It is natural to assume that the largest nodule in a multinodular goiter is the most dangerous, but size alone does not determine cancer risk ^[1][2]. Doctors decide which nodules to biopsy based on a combination of ultrasound features, size thresholds, thyroid function, and your personal medical history ^[1][3]. A smaller nodule with suspicious characteristics is often much more concerning than a large nodule that appears entirely benign on an ultrasound ^[4][5].

Ultrasound Features Tell a Bigger Story Than Size

When your doctor reviews your thyroid ultrasound, they are looking for specific visual patterns that, when combined, suggest a higher risk of malignancy ^[1][6]. Medical guidelines use scoring systems, such as the American College of Radiology’s TI-RADS (Thyroid Imaging Reporting and Data System) or guidelines from the American Thyroid Association (ATA), to assign risk categories based on these features ^[7][8].

A smaller nodule may be selected for an ultrasound-guided fine-needle aspiration (FNA) biopsy over a larger one if it has features such as:

• Irregular or lobulated margins: The edges of the nodule are jagged or spiked, rather than smooth ^[4][9]. (Note: This is different from “ill-defined” margins, which do not carry the same risk).
• Microcalcifications: Tiny flecks of calcium inside the nodule, which show up as bright white spots (punctate echogenic foci) on the ultrasound ^[4][9].
• Taller-than-wide shape: The nodule grows more from front-to-back than side-to-side, which can be a sign of abnormal growth ^[4][9].
• Marked hypoechogenicity: The nodule appears much darker than the surrounding thyroid tissue. While this can increase concern, it is also seen in many benign nodules and is only one part of the puzzle ^[4][9].
• Signs that the nodule is growing outside the thyroid (extrathyroidal extension) or if there are suspicious lymph nodes nearby ^[10][11].

In contrast, a very large nodule might be purely cystic (filled with fluid) or have a “spongiform” appearance (looking like a sponge) ^[5]. These features strongly suggest the nodule is benign and generally do not require a diagnostic biopsy for cancer risk ^[5][6]. However, a large, benign-appearing nodule might still need to be aspirated or surgically treated if it is causing symptoms like difficulty swallowing, breathing issues, or neck pressure.

Example: How Size and Features Work Together (ACR TI-RADS)
Note: Guidelines vary, and your doctor will customize recommendations based on your specific situation.

• TR1 or TR2 (Benign / Not Suspicious): Usually not biopsied for cancer risk, regardless of size ^[7].
• TR3 (Mildly Suspicious): Biopsy considered if the nodule is 2.5 cm or larger ^[7][8][12].
• TR4 (Moderately Suspicious) & TR5 (Highly Suspicious): Biopsied at much smaller size thresholds (such as 1.5 cm or 1.0 cm) because their visual features are more concerning ^[2][8].

The Role of Radionuclide Scanning

If your blood tests show that your TSH (thyroid-stimulating hormone) is low, it suggests your thyroid may be overactive. In this case, your doctor will often consider a radionuclide scan before deciding on biopsies, provided you are not pregnant ^[13][14].

This scan maps the activity of your thyroid and can identify if a specific nodule is producing too much hormone—known as an autonomously functioning or “hot” nodule ^[13][15]. Hot nodules have a lower risk of being cancerous, though the risk is not absolute zero ^[16]. Because of this lower risk, even if a hot nodule is the largest one in your goiter, it is usually excluded from needing a biopsy unless there are other highly suspicious ultrasound findings or clinical concerns ^[13][10][11]. Instead, doctors will focus on evaluating the non-functioning (“cold”) nodules based on their ultrasound features and size ^[13][15]. A “cold” nodule simply means it does not produce excess hormone, not that it is cancerous.

Why Not Biopsy Every Nodule?

When dealing with a multinodular goiter, it might seem safest to biopsy every single nodule. However, medical guidelines specifically recommend against this approach to balance cancer detection with the risks of unnecessary procedures ^[17]:

• High rates of benign nodules: The vast majority of thyroid nodules are benign ^[6][18]. Biopsying every nodule subjects you to unnecessary medical testing without a clear benefit ^[6].
• Indeterminate Results: Depending on the clinic and population, up to 30% of thyroid biopsies come back as “indeterminate,” meaning the cells do not look perfectly normal, but they aren’t clearly cancerous either ^[19][20]. While indeterminate results are often managed with repeat biopsies, molecular testing, or surveillance, they can cause significant anxiety and sometimes lead to diagnostic surgery that turns out to be unnecessary ^[19][21][22].
• Minimizing complications and overtreatment: Every biopsy carries a small risk of complications, such as bleeding or bruising ^[23]. Furthermore, extensive testing can reveal very tiny, slow-growing cancers that might never cause health problems, exposing patients to the risks of surgery and lifelong thyroid hormone replacement ^[24].

What Happens to Nodules That Aren’t Biopsied?

Nodules that do not meet the criteria for a biopsy aren’t simply ignored. They are typically monitored with follow-up ultrasounds over time ^[25][26]. The interval for these follow-ups (often ranging from 1 to 5 years) depends on the nodule’s ultrasound category and size. If a monitored nodule grows significantly or develops new suspicious features, your doctor will reassess it and may recommend a biopsy then.

Tell Your Doctor If…

Clinical history matters just as much as ultrasound features. Be sure to inform your doctor if you have:

• Prior radiation treatment to your head or neck
• A family history of thyroid cancer
• Rapid growth of any nodule
• Unexplained hoarseness or voice changes
• Difficulty swallowing, breathing issues, or a feeling of pressure in your neck

These factors can elevate your risk and change your biopsy plan, even if a nodule is small.

By selectively targeting nodules whose ultrasound risk, size, and clinical context meet guideline criteria, doctors try to find the clinically important cancers while sparing you from unnecessary testing, anxiety, and overtreatment ^[6][25][26].